Suppr超能文献

相似文献

1
Diagnostic Relevance of GATA 3 Expression in Urinary Bladder Carcinoma of Divergent Differentiation and Other Histological Variants.
Indian J Surg Oncol. 2021 Dec;12(4):678-685. doi: 10.1007/s13193-021-01394-6. Epub 2021 Aug 18.
2
Differential expression of GATA-3 in urothelial carcinoma variants.
Hum Pathol. 2014 Jul;45(7):1466-72. doi: 10.1016/j.humpath.2014.02.023. Epub 2014 Mar 15.
3
GATA-3 Expression in all Grades and Different Variants of Primary and Metastatic Urothelial Carcinoma.
Indian J Surg Oncol. 2021 Apr;12(Suppl 1):72-78. doi: 10.1007/s13193-019-01026-0. Epub 2020 Jan 18.
4
Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma.
Indian J Pathol Microbiol. 2019 Apr-Jun;62(2):244-250. doi: 10.4103/IJPM.IJPM_228_18.
5
Expression of Gata Binding Protein 3 as a Prognostic Factor in Urogenital Lesions and Its Association With Morphology.
Cureus. 2023 Nov 29;15(11):e49635. doi: 10.7759/cureus.49635. eCollection 2023 Nov.
8
What Is the Significance of Variant Histology in Urothelial Carcinoma?
Eur Urol Focus. 2020 Jul 15;6(4):653-663. doi: 10.1016/j.euf.2019.09.003. Epub 2019 Sep 15.
9
The Utility of GATA3 in the Diagnosis of Urothelial Carcinomas With Variant Morphologic Patterns.
Appl Immunohistochem Mol Morphol. 2016 Aug;24(7):509-13. doi: 10.1097/PAI.0000000000000221.

引用本文的文献

1
Emerging Concepts in Immuno-Oncology: Insights from Natural Language Processing-Driven Co-Occurrence Analysis.
ACS Omega. 2025 Jun 27;10(27):28587-28614. doi: 10.1021/acsomega.5c00693. eCollection 2025 Jul 15.
2
Occult urothelial carcinoma with mediastinal metastasis: A case report.
Oncol Lett. 2024 Feb 9;27(4):148. doi: 10.3892/ol.2024.14281. eCollection 2024 Apr.
3
Expression of Gata Binding Protein 3 as a Prognostic Factor in Urogenital Lesions and Its Association With Morphology.
Cureus. 2023 Nov 29;15(11):e49635. doi: 10.7759/cureus.49635. eCollection 2023 Nov.

本文引用的文献

1
Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma.
Indian J Pathol Microbiol. 2019 Apr-Jun;62(2):244-250. doi: 10.4103/IJPM.IJPM_228_18.
2
GATA3 immunohistochemical expression in invasive urothelial carcinoma.
Urol Oncol. 2016 Oct;34(10):432.e9-432.e13. doi: 10.1016/j.urolonc.2016.04.016. Epub 2016 May 27.
3
The Utility of GATA3 in the Diagnosis of Urothelial Carcinomas With Variant Morphologic Patterns.
Appl Immunohistochem Mol Morphol. 2016 Aug;24(7):509-13. doi: 10.1097/PAI.0000000000000221.
4
Uroplakin II (UPII), GATA3, and p40 are Highly Sensitive Markers for the Differential Diagnosis of Invasive Urothelial Carcinoma.
Appl Immunohistochem Mol Morphol. 2015 Nov-Dec;23(10):711-6. doi: 10.1097/PAI.0000000000000143.
6
Differential expression of GATA-3 in urothelial carcinoma variants.
Hum Pathol. 2014 Jul;45(7):1466-72. doi: 10.1016/j.humpath.2014.02.023. Epub 2014 Mar 15.
7
GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder.
Am J Surg Pathol. 2013 Nov;37(11):1756-60. doi: 10.1097/PAS.0b013e31829cdba7.
10
Immunohistochemical biomarkers for bladder cancer prognosis.
Int J Urol. 2011 Sep;18(9):616-29. doi: 10.1111/j.1442-2042.2011.02809.x. Epub 2011 Jul 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验